2. Signaling Pathways
  3. Cell Cycle/DNA Damage
  4. Nucleoside Antimetabolite/Analog

Nucleoside Antimetabolite/Analog

Nucleoside Antimetabolite/Analog

Related Products

PDF 2.47 MB

Nucleoside analogues are molecules that act like nucleosides in DNA synthesis. They include a range of antiviral products used to prevent viral replication in infected cells. Nucleoside analogues can be used against hepatitis B virus, hepatitis C virus, herpes simplex, and HIV. Once they are phosphorylated, they work as antimetabolites by being similar enough to nucleotidesto be incorporated into growing DNA strands. Less selective nucleoside analogues are used as chemotherapy agents to treat cancer, eg gemcitabine and 5-FU. Antimetabolite is a chemical that inhibits the use of a metabolite, which is another chemical that is part of normal metabolism. Such substances are often similar in structure to the metabolite that they interfere with, such as the antifolates that interfere with the use of folic acid. The presence of antimetabolites can have toxic effects on cells, such as halting cell growth and cell division, so these compounds are used as chemotherapy for cancer.

Nucleoside Antimetabolite/Analog Related Products (2418):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-180687
    N-Formyl-L-glutamate
    N-Formyl-L-glutamate (N-Formyl-L-glutamic acid) can be obtained from the conversion of L-histidine. N-Formyl-L-glutamate can be degraded into L-glutamate.
    N-Formyl-L-glutamate
  • HY-152445
    3’-Amino-3’-deoxyuridine
    3’-Amino-3’-deoxyuridine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    3’-Amino-3’-deoxyuridine
  • HY-152973
    7'-O-DMT-morpholino thymine
    7'-O-DMT-morpholino thymine is an adenosine analog. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. Its popular products are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277).
    7'-O-DMT-morpholino thymine
  • HY-119530R
    Thiamiprine (Standard)
    Thiamiprine (Standard) is the analytical standard of Thiamiprine. This product is intended for research and analytical applications. Thiamiprine (BW 57-323) is a compound related to azathioprine. Its nucleoside forms are similar to the parent compound in terms of cytotoxicity in vitro (except for the arabinoside). In the rat adjuvant arthritis model in vivo, its riboside and 2'-deoxyriboside are less active than the parent compound. The arabinoside is inactive and nontoxic. It has similar potency to the other parent compounds tested, but has a different safety profile.
    Thiamiprine (Standard)
  • HY-152354
    8-Benzyloxy-3’-deoxyguanosine
    8-Benzyloxy-3’-deoxyguanosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    8-Benzyloxy-3’-deoxyguanosine
  • HY-152368
    8-Hydrazinoadenosine
    8-Hydrazinoadenosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    8-Hydrazinoadenosine
  • HY-138586S
    DMT-dC(ac) Phosphoramidite-13C9, 15N3
    DMT-dC(ac) Phosphoramidite-13C9, 15N3 is the 13C- and 15N-labeled DMT-dC(ac) Phosphoramidite (HY-138586). DMT-dC(ac) Phosphoramidite (compound 30f) is a phosphoramidite derivative that can be used for the oligonucleotide synthesis.
    DMT-dC(ac) Phosphoramidite-<sup>13</sup>C<sub>9</sub>, <sup>15</sup>N<sub>3</sub>
  • HY-137697B
    ddCTP trilithium
    ddCTP trilithium is a type of chain-terminating deoxynucleotide. ddCTP trilithium can be incorporated into the extension primer chain that lacks the 3'-hydroxyl group, thereby terminating primer extension, viral genome replication, and DNA synthesis. ddCTP trilithium can distinguish almost identical RNA through distinguishable extension products in primer extension inhibition experiments. ddCTP trilithium is the active metabolite of Zalcitabine (HY-17392), which can competitively inhibit HIV reverse transcriptase, terminate the synthesis of viral DNA chains, and thereby inhibit HIV replication.
    ddCTP trilithium
  • HY-152300
    N4,N4-Dimethylcytidine
    N4,N4-Dimethylcytidine is a cytidine nucleoside analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities.
    N4,N4-Dimethylcytidine
  • HY-105102
    Netivudine
    		Inhibitor
    Netivudine is a nucleoside analogue with potent anti-varicella zoster virus activity. Netivudine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
    Netivudine
  • HY-152365
    N6,N6-Dimethyl-2’-β-C-methyladenosine
    N6,N6-Dimethyl-2’-β-C-methyladenosine is an adenosine analogue. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. The popular products in this series are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277).
    N6,N6-Dimethyl-2’-β-C-methyladenosine
  • HY-152489
    8-Chloro-2’-deoxy-2’-fluoro inosine
    8-Chloro-2’-deoxy-2’-fluoro inosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    8-Chloro-2’-deoxy-2’-fluoro inosine
  • HY-180776
    S-Inosyl-L-homocysteine
    S-Inosyl-L-homocysteine is a nucleoside metabolite.
    S-Inosyl-L-homocysteine
  • HY-N8525S
    3'-O-Acetylthymidine-13C
    3'-O-Acetylthymidine-13C is the 13C-labeled 3'-O-Acetylthymidine (HY-N8525). 3'-O-Acetylthymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    3'-O-Acetylthymidine-<sup>13</sup>C
  • HY-180616
    (5Z,13E)-9Alpha-hydroxy-11,15-dioxoprosta-5,13-dienoate
    (5Z,13E)-9Alpha-hydroxy-11,15-dioxoprosta-5,13-dienoate (15-Dehydro-prostaglandin D2) is a class of eicosanoids.
    (5Z,13E)-9Alpha-hydroxy-11,15-dioxoprosta-5,13-dienoate
  • HY-180592
    3α,7α-Dihydroxy-24-oxo-5β-cholestan-26-oyl-CoA
    3α,7α-Dihydroxy-24-oxo-5β-cholestan-26-oyl-CoA is a coenzyme A (CoA) ester is involved in bile acid biosynthesis.
    3α,7α-Dihydroxy-24-oxo-5β-cholestan-26-oyl-CoA
  • HY-152998
    2’,3’,5’-Tri-O-acetyl-5-methoxycarbonylmethyl-2-thiouridine
    2’,3’,5’-Tri-O-acetyl-5-methoxycarbonylmethyl-2-thiouridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    2’,3’,5’-Tri-O-acetyl-5-methoxycarbonylmethyl-2-thiouridine
  • HY-152522
    5-Fluoro-4’-C-methyluridine
    5-Fluoro-4’-C-methyluridine is a uridine analogue. Uridine has potential antiepileptic effects, and its analogs can be used to study anticonvulsant and anxiolytic activities, as well as to develop new antihypertensive agents.
    5-Fluoro-4’-C-methyluridine
  • HY-W411295
    5-Methyl-2'-O,4'-C-methylenecytidine
    		98.0%
    5-Methyl-2'-O,4'-C-methylenecytidine is a cytidine nucleoside analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities.
    5-Methyl-2'-O,4'-C-methylenecytidine
  • HY-152655
    6-Ethoxy-9-beta-D-(2-C-methyl-ribofuranosyl)purine
    6-Ethoxy-9-beta-D-(2-C-methyl-ribofuranosyl)purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    6-Ethoxy-9-beta-D-(2-C-methyl-ribofuranosyl)purine